Such strong prevalence of p53 functional deficiency in cancers offered a unique possibility of incorporating sensors of p53 status in gene circuits to empower highly accurate tumor identification and subsequent output production, e.g., to engage immune rewiring only upon sensing the co-occurrence of an onco-TF activation and p53 deficiency (AND–NOT logic). This evidence concerns the gene TP53 and neoplasm.